View of Prevalence of Non-classical Congenital Adrenal hyperplasia among Patients Managed as A polycystic Ovarian Syndrome using 17-Hydroxy-progesterone as A Biomarker

Return to Article Details Prevalence of Non-classical Congenital Adrenal hyperplasia among Patients Managed as A polycystic Ovarian Syndrome using 17-Hydroxy-progesterone as A Biomarker Download Download PDF